Won Kim

TL;DR: A+AVD had superior efficacy to ABVD in the treatment of patients with advanced‐stage Hodgkin's lymphoma, with a 4.9 percentage‐point lower combined risk of progression, death, or noncomplete response and use of subsequent anticancer therapy at 2 years.

TL;DR: By replacing the N-terminal portion of Ang1 with the short coiled-coil domain of cartilage oligomeric matrix protein (COMP), this variant is a soluble, stable, and potent Ang1 variant, COMP-Ang1, which is more potent than native Ang1 in phosphorylating the tyrosine kinase with Ig and epidermal growth factor homology domain 2 (Tie2) receptor and Akt in primary cultured endothelial cells.

TL;DR: Genistein significantly decreased reactive oxygen species production, the expression of intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 proteins, and the translocation of the p65 subunit of nuclear factor-kappaB into the nucleus and the infiltration of macrophages in cisplatin-treated normal human kidney HK-2 cells.